首页 > 最新文献

Hormone Molecular Biology and Clinical Investigation最新文献

英文 中文
Ovarian tissue cryopreservation in Malaysia: a case series. 马来西亚卵巢组织冷冻保存:一个案例系列。
IF 1 Q3 Medicine Pub Date : 2022-12-01 DOI: 10.1515/hmbci-2021-0096
Norazilah Mat Jin, Siti Maisarah Ahmad, Ahmad Mohd Faizal, Abdul Kadir Bin Abdul Karim, Muhammad Azrai Abu

Objectives: We aim to discuss the hematological cancer cases that opted for ovarian tissue cryopreservation (OTC) as fertility preservation before the gonadotoxic chemotherapy agent.

Case presentation: The ovarian tissue cryopreservation (OTC) was started in August 2020 in our center. Up to now, there were four cases have been performed and included in this report. The ovarian tissue cortex was cryopreserved with cryoprotectant using Kitazato™ (Tokyo, Japan) media and fit in the closed system devices. A total of four post-OTC patients were included. The mean age was 24 years old, whereas the mean serum AMH level was 30.43 pmol/L. Most of them were diagnosed with lymphoma, except one was leukemia. All of them received additional GnRH analog following OTC as a chemoprotective agent before cancer treatment. Currently, they are recovering well and on regular follow-up with the hematological department.

Conclusions: Although The OTC is an ultimate option for prepubertal girls, it can be proposed as a good strategy for adult cancer women who could not delay cancer therapy.

目的:探讨在使用促性腺毒素化疗前选择卵巢组织冷冻保存(OTC)作为生育能力保存的血液病病例。病例介绍:我中心于2020年8月启动卵巢组织冷冻保存(OTC)。到目前为止,已经完成了4例,并纳入了本报告。使用Kitazato™(Tokyo, Japan)培养基用冷冻保护剂冷冻保存卵巢组织皮层,并将其放入封闭系统装置中。共纳入4例otc后患者。平均年龄24岁,血清AMH平均值为30.43 pmol/L。除1例白血病外,大部分患者都被诊断为淋巴瘤。在癌症治疗前,所有患者都在OTC后接受了GnRH类似物作为化学保护剂。目前,他们恢复良好,并定期随访血液科。结论:虽然OTC是青春期前女孩的最终选择,但对于不能延迟癌症治疗的成年癌症妇女来说,它是一个很好的策略。
{"title":"Ovarian tissue cryopreservation in Malaysia: a case series.","authors":"Norazilah Mat Jin,&nbsp;Siti Maisarah Ahmad,&nbsp;Ahmad Mohd Faizal,&nbsp;Abdul Kadir Bin Abdul Karim,&nbsp;Muhammad Azrai Abu","doi":"10.1515/hmbci-2021-0096","DOIUrl":"https://doi.org/10.1515/hmbci-2021-0096","url":null,"abstract":"<p><strong>Objectives: </strong>We aim to discuss the hematological cancer cases that opted for ovarian tissue cryopreservation (OTC) as fertility preservation before the gonadotoxic chemotherapy agent.</p><p><strong>Case presentation: </strong>The ovarian tissue cryopreservation (OTC) was started in August 2020 in our center. Up to now, there were four cases have been performed and included in this report. The ovarian tissue cortex was cryopreserved with cryoprotectant using Kitazato™ (Tokyo, Japan) media and fit in the closed system devices. A total of four post-OTC patients were included. The mean age was 24 years old, whereas the mean serum AMH level was 30.43 pmol/L. Most of them were diagnosed with lymphoma, except one was leukemia. All of them received additional GnRH analog following OTC as a chemoprotective agent before cancer treatment. Currently, they are recovering well and on regular follow-up with the hematological department.</p><p><strong>Conclusions: </strong>Although The OTC is an ultimate option for prepubertal girls, it can be proposed as a good strategy for adult cancer women who could not delay cancer therapy.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10765302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The investigation of the frequency of the alpha-1-antitrypsin phenotype in patients with liver cirrhosis. 肝硬化患者α -1-抗胰蛋白酶表型频率的研究。
IF 1 Q3 Medicine Pub Date : 2022-12-01 DOI: 10.1515/hmbci-2022-0001
Mehdi Afsharinasab, Amir Hossein Akbari, Vahid Mirzaei, Mehdi Mahmoodi, Mohammad Reza Hajizadeh, Jamal Amri, Alireza Khoshdel

Objectives: Alpha-1-antitrypsin (AAT) has different phenotypes. Evidence suggests that the abundance of each of these phenotypes may be associated with a disease. The purpose of this study was to evaluate the frequency of AAT phenotypes in patients with liver cirrhosis as well as in healthy individuals.

Methods: In this study, 42 patients with liver cirrhosis were selected. The results of the previous research done by the researcher on healthy individuals were used to construct the control group. After obtaining informed consent, 5 mL of fasting venous blood sample was taken, and phenotypes were analyzed by isoelectric focusing. Data were analyzed using Chi-square and Fisher's exact tests at a significant level of 0.05.

Results: The results of this study indicated that all 42 healthy subjects had an MM allele (100%). However, among 42 patients, 35 (83.3%) had an MM allele, 5 (11.9%) had an MS allele, and 2 (4.8%) had MZ allele. The difference between the two groups was significant (p=0.02). There was no difference between men and women in the allele type (p=0.557).

Conclusions: This study revealed that MS and MZ alleles were observed only in patients with liver cirrhosis, and none of these alleles were found in healthy subjects. Therefore, MS and MZ alleles can be further investigated as risk factors for liver cirrhosis.

目的:α -1抗胰蛋白酶(AAT)具有不同的表型。有证据表明,这些表型的丰富程度可能与疾病有关。本研究的目的是评估肝硬化患者和健康人AAT表型的频率。方法:选取42例肝硬化患者作为研究对象。研究者之前对健康个体的研究结果被用来构建对照组。获得知情同意后,取空腹静脉血5 mL,等电聚焦分析表型。数据分析采用卡方检验和Fisher精确检验,显著水平为0.05。结果:42名健康受试者均存在MM等位基因(100%)。42例患者中,MM等位基因35例(83.3%),MS等位基因5例(11.9%),MZ等位基因2例(4.8%)。两组间差异有统计学意义(p=0.02)。男性和女性在等位基因类型上没有差异(p=0.557)。结论:本研究发现MS和MZ等位基因仅在肝硬化患者中存在,而在健康人群中未发现。因此,MS和MZ等位基因可作为肝硬化的危险因素进行进一步研究。
{"title":"The investigation of the frequency of the alpha-1-antitrypsin phenotype in patients with liver cirrhosis.","authors":"Mehdi Afsharinasab,&nbsp;Amir Hossein Akbari,&nbsp;Vahid Mirzaei,&nbsp;Mehdi Mahmoodi,&nbsp;Mohammad Reza Hajizadeh,&nbsp;Jamal Amri,&nbsp;Alireza Khoshdel","doi":"10.1515/hmbci-2022-0001","DOIUrl":"https://doi.org/10.1515/hmbci-2022-0001","url":null,"abstract":"<p><strong>Objectives: </strong>Alpha-1-antitrypsin (AAT) has different phenotypes. Evidence suggests that the abundance of each of these phenotypes may be associated with a disease. The purpose of this study was to evaluate the frequency of AAT phenotypes in patients with liver cirrhosis as well as in healthy individuals.</p><p><strong>Methods: </strong>In this study, 42 patients with liver cirrhosis were selected. The results of the previous research done by the researcher on healthy individuals were used to construct the control group. After obtaining informed consent, 5 mL of fasting venous blood sample was taken, and phenotypes were analyzed by isoelectric focusing. Data were analyzed using Chi-square and Fisher's exact tests at a significant level of 0.05.</p><p><strong>Results: </strong>The results of this study indicated that all 42 healthy subjects had an MM allele (100%). However, among 42 patients, 35 (83.3%) had an MM allele, 5 (11.9%) had an MS allele, and 2 (4.8%) had MZ allele. The difference between the two groups was significant (p=0.02). There was no difference between men and women in the allele type (p=0.557).</p><p><strong>Conclusions: </strong>This study revealed that MS and MZ alleles were observed only in patients with liver cirrhosis, and none of these alleles were found in healthy subjects. Therefore, MS and MZ alleles can be further investigated as risk factors for liver cirrhosis.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10813146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Esketamine-A quick-acting novel antidepressant without the disadvantages of ketamine. 艾氯胺酮-一种新型快速抗抑郁药,没有氯胺酮的缺点。
IF 1 Q3 Medicine Pub Date : 2022-12-01 DOI: 10.1515/hmbci-2021-0099
Sheikh Shoib, Madhulika Kotra, Sana Javed, Vinh-Son Nguyen, Barikar C Malathesh

Esketamine, which is an S-enantiomer of ketamine, is better than conventional antidepressants and even better than R-ketamine. This article discusses the mechanism of action of Esketamine, how different it is from other antidepressants, its side effect profile, indications for use, various routes of administration and the review of existing literature on Esketamine.

艾氯胺酮是氯胺酮的s对映体,比传统的抗抑郁药更好,甚至比r -氯胺酮更好。本文就艾氯胺酮的作用机制、与其他抗抑郁药的区别、副作用、使用适应症、各种给药途径以及艾氯胺酮的文献进行综述。
{"title":"Esketamine-A quick-acting novel antidepressant without the disadvantages of ketamine.","authors":"Sheikh Shoib,&nbsp;Madhulika Kotra,&nbsp;Sana Javed,&nbsp;Vinh-Son Nguyen,&nbsp;Barikar C Malathesh","doi":"10.1515/hmbci-2021-0099","DOIUrl":"https://doi.org/10.1515/hmbci-2021-0099","url":null,"abstract":"<p><p>Esketamine, which is an S-enantiomer of ketamine, is better than conventional antidepressants and even better than R-ketamine. This article discusses the mechanism of action of Esketamine, how different it is from other antidepressants, its side effect profile, indications for use, various routes of administration and the review of existing literature on Esketamine.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10415243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
An overview of prognostic value of neurologic and cardiac biomarkers in patients with COVID-19 sequelae. 神经和心脏生物标志物对COVID-19后遗症患者预后的价值综述
IF 1 Q3 Medicine Pub Date : 2022-12-01 DOI: 10.1515/hmbci-2022-0015
Madhusudhan Umesh, Vidya Singaravelu, Vandana Daulatabad, Prafull Kamble, Anish Singhal, Nitin Ashok John, Jyoti John

Many studies conducted after the pandemic period revealed that, while COVID-19 primarily injured the lungs, it also affects other organs in the form of cardiovascular complications, metabolic derangements, renal damage, and so on. Although we know that inflammatory cascades, complement activation, and pro-inflammatory cytokines are all involved in vasculitic processes that cause organ damage, we do not know the exact mechanism of complications such as acute respiratory distress syndrome (ARDS), cardiovascular ischemia, deep vein thrombosis, pulmonary thromboembolism, and brain injuries (embolism) that are frequently observed in COVID 19. The currently available biomarkers do not predict the severity of the aforementioned complications. As a result, more specific biomarkers such as serum calcium binding protein (S100B), glial fibrillary acid protein (GFAP), myelin basic protein (MBP), neuron-specific enolase (NSE), hs-TNI, (highly sensitive cardiac troponin) - HBDH, (Hydroxybutyrate Dehydrogenase), CK-MB (creatine kinase myocardial band), ST2 (suppression of tumorigenicity 2) are in need for early detection & improved clinical outcome.

大流行后的许多研究表明,虽然COVID-19主要损害肺部,但它也会以心血管并发症、代谢紊乱、肾脏损害等形式影响其他器官。虽然我们知道炎症级联反应、补体激活和促炎细胞因子都参与了导致器官损伤的血管过程,但我们不知道在COVID - 19中经常观察到的急性呼吸窘迫综合征(ARDS)、心血管缺血、深静脉血栓形成、肺血栓栓塞和脑损伤(栓塞)等并发症的确切机制。目前可用的生物标志物不能预测上述并发症的严重程度。因此,需要更多特异性的生物标志物,如血清钙结合蛋白(S100B)、胶质纤维酸蛋白(GFAP)、髓鞘碱性蛋白(MBP)、神经元特异性烯醇化酶(NSE)、hs-TNI、(高敏感心肌肌钙蛋白)- HBDH、(羟基丁酸脱氢酶)、CK-MB(肌酸激酶心肌带)、ST2(抑制致瘤性2)等,以早期发现和改善临床结果。
{"title":"An overview of prognostic value of neurologic and cardiac biomarkers in patients with COVID-19 sequelae.","authors":"Madhusudhan Umesh,&nbsp;Vidya Singaravelu,&nbsp;Vandana Daulatabad,&nbsp;Prafull Kamble,&nbsp;Anish Singhal,&nbsp;Nitin Ashok John,&nbsp;Jyoti John","doi":"10.1515/hmbci-2022-0015","DOIUrl":"https://doi.org/10.1515/hmbci-2022-0015","url":null,"abstract":"<p><p>Many studies conducted after the pandemic period revealed that, while COVID-19 primarily injured the lungs, it also affects other organs in the form of cardiovascular complications, metabolic derangements, renal damage, and so on. Although we know that inflammatory cascades, complement activation, and pro-inflammatory cytokines are all involved in vasculitic processes that cause organ damage, we do not know the exact mechanism of complications such as acute respiratory distress syndrome (ARDS), cardiovascular ischemia, deep vein thrombosis, pulmonary thromboembolism, and brain injuries (embolism) that are frequently observed in COVID 19. The currently available biomarkers do not predict the severity of the aforementioned complications. As a result, more specific biomarkers such as serum calcium binding protein (S100B), glial fibrillary acid protein (GFAP), myelin basic protein (MBP), neuron-specific enolase (NSE), hs-TNI, (highly sensitive cardiac troponin) - HBDH, (Hydroxybutyrate Dehydrogenase), CK-MB (creatine kinase myocardial band), ST2 (suppression of tumorigenicity 2) are in need for early detection & improved clinical outcome.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10420988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Anti-oxidant effect of metformin through AMPK/SIRT1/PGC-1α/SIRT3- independent GPx1 expression in the heart of mice with endometriosis. 二甲双胍通过AMPK/SIRT1/PGC-1α/SIRT3独立的GPx1表达在子宫内膜异位症小鼠心脏中的抗氧化作用。
IF 1 Q3 Medicine Pub Date : 2022-12-01 DOI: 10.1515/hmbci-2022-0039
Rodrigo Felgueiras, Ana C Neto, Adriana R Rodrigues, Alexandra M Gouveia, Henrique Almeida, Delminda Neves

Objectives: Endometriosis is a gynecological disease associated with an imbalance between oxidative species production and anti-oxidative defenses. In women, endometriosis has been reported to associate with increased incidence of cardiovascular events. As such, this study aimed to analyze the oxidation-responsive AMPK/SIRT1/PGC-1α/SIRT3 pathway in the heart of a mouse model of endometriosis. The effect of metformin, an insulin-sensitizing and anti-oxidative drug with already shown positive results in endometriotic tissue was studied.

Methods: Thirty-six female B6CBA/F1 mice were divided into 4 groups (Control-C, Surgery-induced Endometriosis and Metformin-EM (50 mg/kg/day orally administrated for 3 months), Endometriosis-E and Metformin-M). Immunofluorescent labelling of SIRT1 and SIRT3 was performed in the heart tissue. Assessment of expression of AMPKα, SIRT1, PGC-1α, SIRT3, SOD2, and GPx1 was performed by Western Blotting. The quantification of microRNA(miR)-34a, miR-195, miR-217, miR-155 and miR-421, involved in the regulation of expression of SIRT1 and SIRT3, was performed by Real-Time PCR.

Results: Data showed an increase in phospho-AMPKα and in GPx1 expression in the EM group when compared to the C group, but not in the total AMPK, SIRT1, PGC-1α, SIRT3 and SOD2, suggesting a GPx1 expression increase independently of the AMPK/SIRT1/PGC-1α/SIRT3 pathway. MicroRNAs, excepting miR-217, showed a consistent trend of increase in the M group.

Conclusions: Our study showed that endometriosis does not significantly affect the expression of the components of the AMPK/SIRT1/PGC-1α/SIRT3 pathway in the heart. However, it indicates that an oxidative condition underlying endometriosis is required for metformin to evidence an increment in the expression of the anti-oxidative enzyme GPx1.

目的:子宫内膜异位症是一种与氧化物种产生和抗氧化防御失衡相关的妇科疾病。据报道,在女性中,子宫内膜异位症与心血管事件的发生率增加有关。因此,本研究旨在分析子宫内膜异位症小鼠模型心脏中氧化响应的AMPK/SIRT1/PGC-1α/SIRT3通路。二甲双胍是一种胰岛素增敏和抗氧化药物,已在子宫内膜异位症组织中显示出阳性结果。方法:将36只雌性B6CBA/F1小鼠分为4组(Control-C组、手术性子宫内膜异位症和二甲双胍- em组(50 mg/kg/d口服3个月)、子宫内膜异位症- e组和二甲双胍- m组)。在心脏组织中进行SIRT1和SIRT3的免疫荧光标记。Western Blotting检测AMPKα、SIRT1、PGC-1α、SIRT3、SOD2和GPx1的表达。通过Real-Time PCR定量检测参与SIRT1和SIRT3表达调控的microRNA(miR)-34a、miR-195、miR-217、miR-155和miR-421。结果:数据显示,与C组相比,EM组中phospho-AMPKα和GPx1的表达增加,但AMPK、SIRT1、PGC-1α、SIRT3和SOD2的表达均未增加,表明GPx1的表达增加独立于AMPK/SIRT1/PGC-1α/SIRT3途径。除miR-217外,其他microrna在M组均呈现一致的升高趋势。结论:我们的研究表明,子宫内膜异位症对心脏AMPK/SIRT1/PGC-1α/SIRT3通路组分的表达无显著影响。然而,这表明二甲双胍需要子宫内膜异位症的氧化条件才能证明抗氧化酶GPx1的表达增加。
{"title":"Anti-oxidant effect of metformin through AMPK/SIRT1/PGC-1α/SIRT3- independent GPx1 expression in the heart of mice with endometriosis.","authors":"Rodrigo Felgueiras,&nbsp;Ana C Neto,&nbsp;Adriana R Rodrigues,&nbsp;Alexandra M Gouveia,&nbsp;Henrique Almeida,&nbsp;Delminda Neves","doi":"10.1515/hmbci-2022-0039","DOIUrl":"https://doi.org/10.1515/hmbci-2022-0039","url":null,"abstract":"<p><strong>Objectives: </strong>Endometriosis is a gynecological disease associated with an imbalance between oxidative species production and anti-oxidative defenses. In women, endometriosis has been reported to associate with increased incidence of cardiovascular events. As such, this study aimed to analyze the oxidation-responsive AMPK/SIRT1/PGC-1α/SIRT3 pathway in the heart of a mouse model of endometriosis. The effect of metformin, an insulin-sensitizing and anti-oxidative drug with already shown positive results in endometriotic tissue was studied.</p><p><strong>Methods: </strong>Thirty-six female B6CBA/F1 mice were divided into 4 groups (Control-C, Surgery-induced Endometriosis and Metformin-EM (50 mg/kg/day orally administrated for 3 months), Endometriosis-E and Metformin-M). Immunofluorescent labelling of SIRT1 and SIRT3 was performed in the heart tissue. Assessment of expression of AMPKα, SIRT1, PGC-1α, SIRT3, SOD2, and GPx1 was performed by Western Blotting. The quantification of microRNA(miR)-34a, miR-195, miR-217, miR-155 and miR-421, involved in the regulation of expression of SIRT1 and SIRT3, was performed by Real-Time PCR.</p><p><strong>Results: </strong>Data showed an increase in phospho-AMPKα and in GPx1 expression in the EM group when compared to the C group, but not in the total AMPK, SIRT1, PGC-1α, SIRT3 and SOD2, suggesting a GPx1 expression increase independently of the AMPK/SIRT1/PGC-1α/SIRT3 pathway. MicroRNAs, excepting miR-217, showed a consistent trend of increase in the M group.</p><p><strong>Conclusions: </strong>Our study showed that endometriosis does not significantly affect the expression of the components of the AMPK/SIRT1/PGC-1α/SIRT3 pathway in the heart. However, it indicates that an oxidative condition underlying endometriosis is required for metformin to evidence an increment in the expression of the anti-oxidative enzyme GPx1.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10476324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of high-intensity interval training on serum and adipose tissues vaspin levels in rats fed a high-fat high-sucrose diet. 高强度间歇训练对高脂高糖饮食大鼠血清和脂肪组织血管素水平的影响。
IF 1 Q3 Medicine Pub Date : 2022-12-01 DOI: 10.1515/hmbci-2021-0107
Ali Delpisheh, Alireza Safarzade

Background: Vaspin is an adipocytokine with insulin-sensitizing and anti-inflammatory traits.

Objectives: The purpose of this study was to evaluate the effect of high-intensity interval training (HIIT) on serum, visceral and subcutaneous adipose tissue vaspin levels in rats exposed to a diet high in fat and sugar (HFS).

Materials and methods: Thirty-two male Wistar rats were randomly divided into HFS and standard diet (SD) groups. After 12 weeks, each group was divided into sedentary and HIIT groups. HIIT program was performed 3 times/week for 8 weeks. Retroperitoneal adipose tissue, inguinal adipose tissue and serum were collected to analyze vaspin levels. Also, serum glucose and insulin levels, insulin resistance index (HOMA-IR) and retroperitoneal and inguinal fat weights were measured.

Results: HFS significantly increased weight gain, weight of inguinal (p=0.001) and retroperitoneal fat depots (p<0.001), serum glucose levels (p<0.001) and HOMA-IR (p<0.001). The HIIT was able to decline weight gain and fat mass (p<0.05) but did not affect inguinal and retroperitoneal fat depots' vaspin levels. Eight weeks' HIIT significantly increased serum vaspin (p=0.002) and decreased insulin (p=0.001) levels only in rats fed with SD.

Conclusions: Although the HIIT program can cause significantly reducing effects on weight gain and fat depots' weights, it does not effect on circulating and fat depots' vaspin levels in rats fed an HFS.

背景:Vaspin是一种具有胰岛素增敏和抗炎特性的脂肪细胞因子。目的:本研究的目的是评估高强度间歇训练(HIIT)对暴露于高脂高糖饮食(HFS)的大鼠血清、内脏和皮下脂肪组织血管素水平的影响。材料与方法:32只雄性Wistar大鼠随机分为高脂饲料组和标准饲料组。12周后,每组分为久坐组和HIIT组。HIIT训练3次/周,持续8周。收集腹膜后脂肪组织、腹股沟脂肪组织及血清,分析血管素水平。同时测定血清葡萄糖和胰岛素水平、胰岛素抵抗指数(HOMA-IR)以及腹膜后和腹股沟脂肪重量。结果:HFS显著增加了大鼠的体重增加、腹股沟体重(p=0.001)和腹膜后脂肪库(p)。结论:虽然HIIT方案可以显著降低HFS喂养大鼠的体重增加和脂肪库的重量,但它对循环和脂肪库的血管素水平没有影响。
{"title":"The effect of high-intensity interval training on serum and adipose tissues vaspin levels in rats fed a high-fat high-sucrose diet.","authors":"Ali Delpisheh,&nbsp;Alireza Safarzade","doi":"10.1515/hmbci-2021-0107","DOIUrl":"https://doi.org/10.1515/hmbci-2021-0107","url":null,"abstract":"<p><strong>Background: </strong>Vaspin is an adipocytokine with insulin-sensitizing and anti-inflammatory traits.</p><p><strong>Objectives: </strong>The purpose of this study was to evaluate the effect of high-intensity interval training (HIIT) on serum, visceral and subcutaneous adipose tissue vaspin levels in rats exposed to a diet high in fat and sugar (HFS).</p><p><strong>Materials and methods: </strong>Thirty-two male Wistar rats were randomly divided into HFS and standard diet (SD) groups. After 12 weeks, each group was divided into sedentary and HIIT groups. HIIT program was performed 3 times/week for 8 weeks. Retroperitoneal adipose tissue, inguinal adipose tissue and serum were collected to analyze vaspin levels. Also, serum glucose and insulin levels, insulin resistance index (HOMA-IR) and retroperitoneal and inguinal fat weights were measured.</p><p><strong>Results: </strong>HFS significantly increased weight gain, weight of inguinal (p=0.001) and retroperitoneal fat depots (p<0.001), serum glucose levels (p<0.001) and HOMA-IR (p<0.001). The HIIT was able to decline weight gain and fat mass (p<0.05) but did not affect inguinal and retroperitoneal fat depots' vaspin levels. Eight weeks' HIIT significantly increased serum vaspin (p=0.002) and decreased insulin (p=0.001) levels only in rats fed with SD.</p><p><strong>Conclusions: </strong>Although the HIIT program can cause significantly reducing effects on weight gain and fat depots' weights, it does not effect on circulating and fat depots' vaspin levels in rats fed an HFS.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10476325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypoxia-inducible factor-1α and ischemia-modified albumin levels in intensive care COVID-19 Patients. 重症监护COVID-19患者缺氧诱导因子-1α和缺血修饰白蛋白水平
IF 1 Q3 Medicine Pub Date : 2022-12-01 DOI: 10.1515/hmbci-2022-0024
Kamile Yucel, Ali Fuat Gurbuz

Objectives: In this study, it was aimed to evaluate the hypoxia-inducible factor-1α (HIF-1α) and ischemia-modified albumin (IMA) levels of patients diagnosed with COVID-19 in the intensive care unit (ICU) and healthy controls. To our knowledge, this is the first study investigate HIF-1α and IMA levels in COVID-19 patients in ICUs and comparing them with a healthy control group. For this reason, our study is original and will contribute to the literature.

Methods: A total of 70 intensive care patients diagnosed with COVID-19, and 72 healthy controls were included in the study.

Results: When we compared the patient and healthy control group; there were no statistically significant differences between the groups in terms of age and gender (p>0.05). No exitus was observed in the patient group. We found weak correlation between HIF-1α and IMA (r: 0.320). However, there were statistically significant differences in HIF-1α and IMA levels in the patient group. The receiver operating characteristic (ROC) curve demonstrated an area under curve (AUC) value of 0.651 for HIF-1α and 0.937 for IMA.

Conclusions: The HIF-1α and IMA levels were significantly higher among COVID-19 patients in ICU compared with healthy controls. HIF-1α and IMA levels can be used as reliable markers for the prognosis of COVID-19.

目的:本研究旨在评估重症监护病房(ICU)确诊的COVID-19患者和健康对照者的缺氧诱导因子-1α (HIF-1α)和缺血修饰白蛋白(IMA)水平。据我们所知,这是第一个研究icu中COVID-19患者HIF-1α和IMA水平并与健康对照组进行比较的研究。因此,我们的研究是原创的,将对文献有所贡献。方法:将70例确诊为COVID-19的重症监护患者和72例健康对照纳入研究。结果:患者与健康对照组比较;各组间年龄、性别差异无统计学意义(p>0.05)。患者组未见出血性休克。我们发现HIF-1α与IMA之间存在弱相关性(r: 0.320)。然而,患者组HIF-1α和IMA水平差异有统计学意义。受试者工作特征(ROC)曲线显示HIF-1α的曲线下面积(AUC)为0.651,IMA为0.937。结论:ICU新冠肺炎患者HIF-1α和IMA水平明显高于健康对照组。HIF-1α和IMA水平可作为COVID-19预后的可靠指标。
{"title":"Hypoxia-inducible factor-1α and ischemia-modified albumin levels in intensive care COVID-19 Patients.","authors":"Kamile Yucel,&nbsp;Ali Fuat Gurbuz","doi":"10.1515/hmbci-2022-0024","DOIUrl":"https://doi.org/10.1515/hmbci-2022-0024","url":null,"abstract":"<p><strong>Objectives: </strong>In this study, it was aimed to evaluate the hypoxia-inducible factor-1α (HIF-1α) and ischemia-modified albumin (IMA) levels of patients diagnosed with COVID-19 in the intensive care unit (ICU) and healthy controls. To our knowledge, this is the first study investigate HIF-1α and IMA levels in COVID-19 patients in ICUs and comparing them with a healthy control group. For this reason, our study is original and will contribute to the literature.</p><p><strong>Methods: </strong>A total of 70 intensive care patients diagnosed with COVID-19, and 72 healthy controls were included in the study.</p><p><strong>Results: </strong>When we compared the patient and healthy control group; there were no statistically significant differences between the groups in terms of age and gender (p>0.05). No exitus was observed in the patient group. We found weak correlation between HIF-1α and IMA (r: 0.320). However, there were statistically significant differences in HIF-1α and IMA levels in the patient group. The receiver operating characteristic (ROC) curve demonstrated an area under curve (AUC) value of 0.651 for HIF-1α and 0.937 for IMA.</p><p><strong>Conclusions: </strong>The HIF-1α and IMA levels were significantly higher among COVID-19 patients in ICU compared with healthy controls. HIF-1α and IMA levels can be used as reliable markers for the prognosis of COVID-19.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10415238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Selective estrogen receptor α and β antagonist aggravate cardiovascular dysfunction in type 2 diabetic ovariectomized female rats. 选择性雌激素受体α和β拮抗剂加重2型糖尿病去卵巢雌性大鼠心血管功能障碍。
IF 1 Q3 Medicine Pub Date : 2022-12-01 DOI: 10.1515/hmbci-2021-0073
Hossein Azizian, Zeinab Farhadi, Mohammad Khaksari

Objectives: Type 2 diabetes (T2D) is a major risk factor for cardiovascular disorders (CVD), characterized by pathological diastolic as well as systolic dysfunction, ventricular dilation, and cardiomyocyte hypertrophy. CVD is the main cause of death in postmenopausal women. Estradiol (E2) has protective effects on cardiovascular function. The biological effects of E2 are mainly mediated by classical estrogen receptors (ERs). The present study aimed to investigate the cardioprotective effects of classical ERs in ovariectomized (OVX) diabetic female rats.

Methods: T2D was induced in female rats by high-fat diet feeding along with a low dose of streptozotocin. Then diabetic animals were divided into eight groups: Sham-control, OVX, OVX + Vehicle (Veh), OVX + E2, OVX + E2 + MPP (ERα antagonist), OVX + E2 + PHTPP (ERβ antagonist), OVX + E2 + Veh, OVX + E2 + MPP + PHTPP. Animals received E2, MPP, and PHTPP every four days for 28 days. At the end blood was collected, serum separated, and used for biochemical parameters. Heart tissue was used for cardiac angiotensin II and cytokines measurement.

Results: E2 treatment improved the metabolic disorders caused by T2D, and its receptor antagonists intensified the effects of T2D on the metabolic status. Also, E2 therapy decreased cardiac inflammatory cytokines, and MPP and PHTPP increased cardiac inflammation by increasing TNF-α and IL-6 and decreasing IL-10.

Conclusions: Classical ERs have protective effects on diabetic hearts by improving the metabolic status and inflammatory balance.

目的:2型糖尿病(T2D)是心血管疾病(CVD)的主要危险因素,其特征是病理性舒张和收缩功能障碍、心室扩张和心肌细胞肥大。心血管疾病是绝经后妇女死亡的主要原因。雌二醇(E2)对心血管功能有保护作用。E2的生物学效应主要由经典雌激素受体介导。本研究旨在探讨经典雌激素对去卵巢(OVX)糖尿病雌性大鼠的心脏保护作用。方法:采用高脂饲料加低剂量链脲佐菌素诱导雌性大鼠T2D。然后将糖尿病动物分为8组:假对照、OVX、OVX + Vehicle (Veh)、OVX + E2、OVX + E2 + MPP (ERα拮抗剂)、OVX + E2 + PHTPP (ERβ拮抗剂)、OVX + E2 + Veh、OVX + E2 + MPP + PHTPP。动物每4天接受E2、MPP和PHTPP治疗,共28天。最后采集血液,分离血清,用于生化指标。心脏组织用于测量心脏血管紧张素II和细胞因子。结果:E2治疗可改善T2D引起的代谢紊乱,其受体拮抗剂可增强T2D对代谢状态的影响。E2治疗降低心脏炎症因子,MPP和PHTPP通过增加TNF-α和IL-6,降低IL-10增加心脏炎症。结论:经典er通过改善糖尿病心脏的代谢状态和炎症平衡,对糖尿病心脏具有保护作用。
{"title":"Selective estrogen receptor α and β antagonist aggravate cardiovascular dysfunction in type 2 diabetic ovariectomized female rats.","authors":"Hossein Azizian,&nbsp;Zeinab Farhadi,&nbsp;Mohammad Khaksari","doi":"10.1515/hmbci-2021-0073","DOIUrl":"https://doi.org/10.1515/hmbci-2021-0073","url":null,"abstract":"<p><strong>Objectives: </strong>Type 2 diabetes (T2D) is a major risk factor for cardiovascular disorders (CVD), characterized by pathological diastolic as well as systolic dysfunction, ventricular dilation, and cardiomyocyte hypertrophy. CVD is the main cause of death in postmenopausal women. Estradiol (E2) has protective effects on cardiovascular function. The biological effects of E2 are mainly mediated by classical estrogen receptors (ERs). The present study aimed to investigate the cardioprotective effects of classical ERs in ovariectomized (OVX) diabetic female rats.</p><p><strong>Methods: </strong>T2D was induced in female rats by high-fat diet feeding along with a low dose of streptozotocin. Then diabetic animals were divided into eight groups: Sham-control, OVX, OVX + Vehicle (Veh), OVX + E2, OVX + E2 + MPP (ERα antagonist), OVX + E2 + PHTPP (ERβ antagonist), OVX + E2 + Veh, OVX + E2 + MPP + PHTPP. Animals received E2, MPP, and PHTPP every four days for 28 days. At the end blood was collected, serum separated, and used for biochemical parameters. Heart tissue was used for cardiac angiotensin II and cytokines measurement.</p><p><strong>Results: </strong>E2 treatment improved the metabolic disorders caused by T2D, and its receptor antagonists intensified the effects of T2D on the metabolic status. Also, E2 therapy decreased cardiac inflammatory cytokines, and MPP and PHTPP increased cardiac inflammation by increasing TNF-α and IL-6 and decreasing IL-10.</p><p><strong>Conclusions: </strong>Classical ERs have protective effects on diabetic hearts by improving the metabolic status and inflammatory balance.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10450738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Association between TP53 Arg72Pro variant and recurrent pregnancy loss in the Greek population. 希腊人群中TP53 Arg72Pro变异与复发性妊娠丢失之间的关系
IF 1 Q3 Medicine Pub Date : 2022-12-01 DOI: 10.1515/hmbci-2021-0093
Dimitra Dedousi, Despoina Mavrogianni, Myrto Papamentzelopoulou, Sofoklis Stavros, Rami Raouasnte, Dimitris Loutradis, Peter Drakakis

Objectives: The present case-control study investigates whether TP53 Arg72Pro variant (rs1042522) serves as a risk factor for recurrent pregnancy loss (RPL) in Greek women.

Methods: The study group consisted of 100 patients with at least two miscarriages of unexplained etiology, before the 24th week of gestation. The control group included 106 women with no pregnancy loss history. DNA was extracted and genotyped using specific primers for PCR amplification of the Arg72 and Pro72 alleles. Sanger sequencing was used for the discrimination between heterozygotes and homozygotes for Arg72Pro variant.

Results: This is the first study demonstrating the statistically significant higher frequency of TP53 Arg72Pro variant in Greek RPL women compared to controls (38% vs. 6.6%; OR=8.6682, 95% CI: 3.6446-20.6160; p<0.0001). GC genotype (Arg/Pro) and CC genotype (Pro/Pro) were statistically more common in RPL patients than in controls (16% vs. 1.9%; p=0.0027, and 22 vs. 4.7%; p=0.0008, respectively). C allele frequency was statistically significant higher in RPL group than in controls (30.0 vs. 5.7%; p<0.0001). According to the inheritance mode analysis, the model that best fit the data was the dominant model (OR=8.67, 95% CI=3.64-20.62; p<0.0001).

Conclusions: The is the first study disclosing strong evidence that TP53 rs1042522 is significantly associated with a higher risk for recurrent pregnancy loss in Greek women following a dominant model, thus, serving as a genetic marker for identifying women at increased risk of recurrent miscarriages.

目的:本病例对照研究探讨TP53 Arg72Pro变异(rs1042522)是否作为希腊妇女复发性妊娠丢失(RPL)的危险因素。方法:研究对象为100例妊娠24周前至少2次原因不明流产患者。对照组包括106名无流产史的妇女。提取DNA,用特异性引物进行基因分型,扩增Arg72和Pro72等位基因。采用Sanger测序法对Arg72Pro的杂合子和纯合子进行区分。结果:这是第一个证明希腊RPL女性中TP53 Arg72Pro变异频率比对照组高(38% vs. 6.6%;Or =8.6682, 95% ci: 3.6446-20.6160;结论:该研究首次揭示了强有力的证据,表明TP53 rs1042522与希腊女性复发性流产的高风险显著相关,因此,TP53 rs1042522可作为识别复发性流产风险增加女性的遗传标记。
{"title":"Association between <i>TP53</i> Arg72Pro variant and recurrent pregnancy loss in the Greek population.","authors":"Dimitra Dedousi,&nbsp;Despoina Mavrogianni,&nbsp;Myrto Papamentzelopoulou,&nbsp;Sofoklis Stavros,&nbsp;Rami Raouasnte,&nbsp;Dimitris Loutradis,&nbsp;Peter Drakakis","doi":"10.1515/hmbci-2021-0093","DOIUrl":"https://doi.org/10.1515/hmbci-2021-0093","url":null,"abstract":"<p><strong>Objectives: </strong>The present case-control study investigates whether <i>TP53</i> Arg72Pro variant (rs1042522) serves as a risk factor for recurrent pregnancy loss (RPL) in Greek women.</p><p><strong>Methods: </strong>The study group consisted of 100 patients with at least two miscarriages of unexplained etiology, before the 24th week of gestation. The control group included 106 women with no pregnancy loss history. DNA was extracted and genotyped using specific primers for PCR amplification of the Arg72 and Pro72 alleles. Sanger sequencing was used for the discrimination between heterozygotes and homozygotes for Arg72Pro variant.</p><p><strong>Results: </strong>This is the first study demonstrating the statistically significant higher frequency of <i>TP53</i> Arg72Pro variant in Greek RPL women compared to controls (38% vs. 6.6%; OR=8.6682, 95% CI: 3.6446-20.6160; p<0.0001). GC genotype (Arg/Pro) and CC genotype (Pro/Pro) were statistically more common in RPL patients than in controls (16% vs. 1.9%; p=0.0027, and 22 vs. 4.7%; p=0.0008, respectively). C allele frequency was statistically significant higher in RPL group than in controls (30.0 vs. 5.7%; p<0.0001). According to the inheritance mode analysis, the model that best fit the data was the dominant model (OR=8.67, 95% CI=3.64-20.62; p<0.0001).</p><p><strong>Conclusions: </strong>The is the first study disclosing strong evidence that <i>TP53</i> rs1042522 is significantly associated with a higher risk for recurrent pregnancy loss in Greek women following a dominant model, thus, serving as a genetic marker for identifying women at increased risk of recurrent miscarriages.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10408017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential tumor marker for hepatocellular carcinoma identification: PI3K and pro-inflammatory cytokines (TGF-β, IL-1, and IL-6). 鉴别肝癌的潜在肿瘤标志物:PI3K和促炎细胞因子(TGF-β、IL-1和IL-6)。
IF 1 Q3 Medicine Pub Date : 2022-12-01 DOI: 10.1515/hmbci-2022-0028
Fahimeh Tabakhiyan, Amirabbas Mir, Vahid Vahedian

Objectives: Hepatocellular carcinoma (HCC), the most common form of liver cancer, is a leading cause of tumor-associated mortality worldwide. Diagnosis based upon non-invasive criteria is currently challenged by the need for molecular information that requires tissue or liquid biopsies. The progression of HCC is often associated with chronic inflammation, expression levels of inflammatory mediators, chemokine, and cytokines. In this study, we try to evaluate the PI3K and pro-inflammatory cytokines, TGF-β, IL-1, and IL-6 expression level in patients with liver cancer.

Materials and methods: The kupffer cells were isolated from patient's specimens. Real-time PCR was applied to evaluate the expression level of PI3K in cell lines or tumors. The concentrations of TGF-β, IL-1, and IL-6 were measured by the quantitative ELISA kit.

Results: PI3K mRNA expression in cancer cells was increased markedly vs. normal cells. The ELISA results demonstrated over expression of TGF-β, IL-1, and IL-6 in patients and positive correlation between tumor size and stage.

Discussion: This study suggests that targeting the expression level of PI3K and pro-inflammatory chemokine and cytokines, TGF-β, IL-1, and IL-6, may be a potential diagnostic strategy in HCC patients.

目的:肝细胞癌(HCC)是最常见的肝癌形式,是全球肿瘤相关死亡的主要原因。基于非侵入性标准的诊断目前受到需要组织或液体活检的分子信息的挑战。HCC的进展通常与慢性炎症、炎症介质、趋化因子和细胞因子的表达水平有关。在本研究中,我们试图评估肝癌患者PI3K和促炎细胞因子、TGF-β、IL-1和IL-6的表达水平。材料和方法:从患者标本中分离kupffer细胞。Real-time PCR检测PI3K在细胞系或肿瘤中的表达水平。采用定量ELISA试剂盒检测TGF-β、IL-1、IL-6的浓度。结果:肿瘤细胞中PI3K mRNA的表达明显高于正常细胞。ELISA结果显示TGF-β、IL-1、IL-6在患者体内过表达,肿瘤大小与分期呈正相关。讨论:本研究提示,针对PI3K及促炎趋化因子和细胞因子TGF-β、IL-1、IL-6的表达水平,可能是HCC患者的潜在诊断策略。
{"title":"Potential tumor marker for hepatocellular carcinoma identification: PI3K and pro-inflammatory cytokines (TGF-β, IL-1, and IL-6).","authors":"Fahimeh Tabakhiyan,&nbsp;Amirabbas Mir,&nbsp;Vahid Vahedian","doi":"10.1515/hmbci-2022-0028","DOIUrl":"https://doi.org/10.1515/hmbci-2022-0028","url":null,"abstract":"<p><strong>Objectives: </strong>Hepatocellular carcinoma (HCC), the most common form of liver cancer, is a leading cause of tumor-associated mortality worldwide. Diagnosis based upon non-invasive criteria is currently challenged by the need for molecular information that requires tissue or liquid biopsies. The progression of HCC is often associated with chronic inflammation, expression levels of inflammatory mediators, chemokine, and cytokines. In this study, we try to evaluate the PI3K and pro-inflammatory cytokines, TGF-β, IL-1, and IL-6 expression level in patients with liver cancer.</p><p><strong>Materials and methods: </strong>The kupffer cells were isolated from patient's specimens. Real-time PCR was applied to evaluate the expression level of PI3K in cell lines or tumors. The concentrations of TGF-β, IL-1, and IL-6 were measured by the quantitative ELISA kit.</p><p><strong>Results: </strong>PI3K mRNA expression in cancer cells was increased markedly vs. normal cells. The ELISA results demonstrated over expression of TGF-β, IL-1, and IL-6 in patients and positive correlation between tumor size and stage.</p><p><strong>Discussion: </strong>This study suggests that targeting the expression level of PI3K and pro-inflammatory chemokine and cytokines, TGF-β, IL-1, and IL-6, may be a potential diagnostic strategy in HCC patients.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10765314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Hormone Molecular Biology and Clinical Investigation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1